ROYCE & ASSOCIATES LP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2017$3,400,000
-17.5%
50,0000.0%0.02%
-14.8%
Q3 2017$4,120,000
-33.3%
50,000
-24.2%
0.03%
-34.1%
Q2 2017$6,180,000
+27.7%
66,000
-13.2%
0.04%
+28.1%
Q1 2017$4,839,000
+43.3%
76,0000.0%0.03%
+45.5%
Q4 2016$3,376,00076,0000.02%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2018
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders